Genetic research watchdog organizations
- GeneWatch, UK
- Council for Responsible Genetics, US
- Sunshine Project, Hamburg, Germany, and Austin, Texas
This is a list of organizations involved in genetics research.
Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology.
The Texas A&M Institute of Biosciences and Technology (IBT), a component of Texas A&M Health, and The Texas A&M University System, is located in the world's largest medical center, the Texas Medical Center, in Houston, Texas. The institute provides a bridge between Texas A&M University System scientists and other institutions' researchers working in the Texas Medical Center and the biomedical and biotechnology research community in Houston. It emphasizes collaboration between member scientists and others working in all the fields of the biosciences and biotechnology. IBT encourages its scientists to transfer discoveries made in their laboratories to the clinic and marketplace.
Tom Maniatis, is an American professor of molecular and cellular biology. He is a professor at Columbia University, and serves as the Scientific Director and CEO of the New York Genome Center.
The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.
The Eli and Edythe L. Broad Institute of MIT and Harvard, often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and it partners with the Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.
David Botstein is an American biologist serving as the chief scientific officer of Calico. He served as the director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University from 2003 to 2013, where he remains an Anthony B. Evnin Professor of Genomics.
The Institute of Medical Science is an ancillary establishment of Tokyo University. It succeeded the Institute of Infectious Diseases established in 1892 and is the foremost institute for medical and bioscience research in Japan.
Dietrich A. Stephan is an American human geneticist and entrepreneur who works in personalized medicine. Stephan is currently CEO of NeuBase Therapeutics and a General Partner in Cyto Ventures. Before NeuBase, Stephan was CEO of LifeX and Chairman and Professor of Human Genetics at the University of Pittsburgh. Prior, he was founding Chairman of the Neurogenomics Division at the Translational Genomics Research Institute. Stephan has founded or co-founded 14 biotechnology companies and advised many others. Stephan was co-founder of Navigenics, a personal genetics company.
Edison T. Liu is an American chemist who is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.
Eric D. Green is an American genomics researcher who had significant involvement in the Human Genome Project. He is the director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH), a position he has held since 2009.
The School of Biological Sciences is a research-led academic community at the University of East Anglia. It works with partners in industry on a range of activities, including translating research discoveries into products, making knowledge and research expertise available through consultancies, contract research and provision of analytical services, as well as partnering industry in training both undergraduate and postgraduate students.
Andres Metspalu is an Estonian geneticist and member of the Estonian Academy of Sciences.
B K Thelma commonly known as Bittianda Kuttapa Thelma is a professor in the Department of Genetics at the University of Delhi, South Campus, New Delhi, India. She is the Principal investigator and Co-ordinator of the Centre of excellence on Genomes Sciences and Predictive Medicine funded by the Govt. of India. She is also the Co-ordinator of a major project on newborn screening for inborn errors of metabolism in Delhi state which aims to demonstrate the feasibility of mandatory screening of newborns in the country and to generate epidemiological data for the testable IEMs in the genetically distinct Indian population, for the first time.
The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.
Elaine Ann Ostrander is an American geneticist at the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds a number of professional academic appointments, currently serving as Distinguished and Senior Investigator and head of the NHGRI Section of Comparative Genomics; and Chief of the Cancer Genetics and Comparative Genomics Branch. She is known for her research on prostate cancer susceptibility in humans and for conducting genetic investigations with the Canis familiaris —the domestic dog— model, which she has used to study disease susceptibility and frequency and other aspects of natural variation across mammals. In 2007, her laboratory showed that much of the variation in body size of domestic dogs is due to sequence changes in a single gene encoding a growth-promoting protein.
Nicole Soranzo is an Italian-British senior group leader in human genetics at the Wellcome Sanger Institute, Professor of Human Genetics at the University of Cambridge. She is an internationally recognised Human Geneticist who has focused on the application of cutting edge genomic technologies to study the spectrum of human genetic variation associated with cardio-metabolic and immune diseases. She has led many large-scale discovery efforts including more than 1,000 novel genetic variants associated with cardio-metabolic diseases and their risk factors as well as establishing the HaemGen consortium, which is a worldwide effort to discover genetic determinants of blood cell formation and also interpretation of the downstream consequences of sequence variation through a host of integrative analyses and functional approaches.
The African Society of Human Genetics (AfSHG) is a learned society and professional membership organization focused on the study of human genetics and genomics in Africans, and open to researchers who are interested in the subject. It has played a role in founding several national genetics societies, and is affiliated with the societies of Cameroon, the Democratic Republic of the Congo, Mali, Egypt, Rwanda, Senegal, South Africa, and Tanzania.
Lyn Robyn Griffiths is an Australian academic who serves as Distinguished Professor of molecular genetics at Queensland University of Technology, where she is director of the Centre for Genomics and Personalised Health, the Genomics Research Centre and the BridgeTech Programs. Griffiths is internationally renowned for her work in the discovery of the genetics of migraine headaches.
Fyodor Dmitriyevich Urnov is Russian-born biomedical researcher and who has played a leading role in the field of genome editing. He is a Professor of Genetics, Genomics, and Development at the University of California, Berkeley and Director of the Center for Translational Genomics at the university's Innovative Genomics Institute. In 2005 Urnov and his colleagues coined the term "genome editing" and demonstrated the first use of ZFNs to edit DNA in human cells. Urnov is considered a pioneering figure in the field of genome editing and his work has been cited widely.
Ludmila Prokunina-Olsson is a molecular medical geneticist who conducts genetic and functional analyses downstream of genome-wide association studies (GWAS) for various human traits, including cancer, immune and infectious diseases. She is chief of the Laboratory of Translational Genomics (LTG) at the National Cancer Institute.
